Ectopic adrenocorticotropic hormone syndrome.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMID 7705280)

Published in Endocr Rev on December 01, 1994

Authors

B L Wajchenberg1, B B Mendonca, B Liberman, M A Pereira, P C Carneiro, A Wakamatsu, M A Kirschner

Author Affiliations

1: Endocrine Section, Adolfo Lutz Institute, Sao Paulo, Brazil.

Articles citing this

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67

Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer (2011) 1.44

Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol (2014) 1.25

Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab (2010) 1.24

Retinoic acid prevents experimental Cushing syndrome. J Clin Invest (2001) 1.05

Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer (2006) 0.96

Comparative Analysis of Clinical, Hormonal and Morphological Studies in Patients with Neuroendocrine ACTH-Producing Tumours. Int J Endocrinol (2013) 0.92

Endoscopic bilateral adrenalectomy in patients with ectopic Cushing's syndrome. Surg Endosc (2011) 0.91

Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review. J Clin Endocrinol Metab (2015) 0.88

Neuroendocrine carcinoma of the ampulla of Vater causing ectopic adrenocorticotropic hormone-dependent Cushing's syndrome. Mol Clin Oncol (2016) 0.81

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an unusual cause of cyclical ectopic adrenocorticotrophic syndrome. Br J Radiol (2011) 0.80

Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome. Endocrinol Metab (Seoul) (2014) 0.76

Ectopic adrenocorticotropic hormone syndrome caused by neuroendocrine tumors of the thymus: 30-year experience with 16 patients at a single institute in the People's Republic of China. Onco Targets Ther (2016) 0.75

Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion from a Meckel diverticulum neuroendocrine tumor: case report. BMC Endocr Disord (2015) 0.75

Paraneoplastic Cushing's syndrome associated with bronchopulmonary carcinoid tumor in youth: A case report and review of the literature. Oncol Lett (2016) 0.75

A case of small cell carcinoma of the vagina. Rare Tumors (2013) 0.75

Severe hypokalemia, metabolic alkalosis and hypertension in a 54 year old male with ectopic ACTH syndrome: a case report. Cases J (2009) 0.75

Small cell lung cancer presenting as severe thrombocytopenia and refractory hypokalemia. Case Rep Oncol Med (2014) 0.75

Atypical or typical adrenocorticotropic hormone-producing pulmonary carcinoids and the usefulness of 11C-5-hydroxytryptophan positron emission tomography: two case reports. J Med Case Rep (2013) 0.75

Periodic hypokalemia associated with cyclic Cushing's syndrome. CEN Case Rep (2013) 0.75

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome. Case Rep Endocrinol (2016) 0.75

Comparison of 68Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome. Endocr Connect (2016) 0.75

Metastatic Pancreatic Neuroendocrine Tumor that Progressed to Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome with Growth Hormone-releasing Hormone (GHRH) Production. Intern Med (2016) 0.75

An Ectopic ACTH Secreting Metastatic Parotid Tumour. Case Rep Endocrinol (2016) 0.75

Articles by these authors

Changes in physical activity patterns in the United States, by sex and cross-sectional age. Med Sci Sports Exerc (2000) 4.63

Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA (1999) 3.34

Adrenocortical carcinoma: clinical and laboratory observations. Cancer (2000) 2.64

Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet (1994) 2.35

MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases--preliminary clinical experience. Ann Oncol (2006) 1.92

Increased estrogen production in obese men. J Clin Endocrinol Metab (1979) 1.89

Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc (2000) 1.81

Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone. Recent Prog Horm Res (1966) 1.74

Influence of leisure time physical activity and television watching on atherosclerosis risk factors in the NHLBI Family Heart Study. Atherosclerosis (2000) 1.70

Antinociceptive properties of chalcones. Structure-activity relationships. Arch Pharm (Weinheim) (2001) 1.54

Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab (2010) 1.54

The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) (1993) 1.49

The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol Appl Pharmacol (1987) 1.47

Nongenetic male pseudohermaphroditism and reduced prenatal growth. N Engl J Med (2001) 1.45

Treatment of hirsutism in women with flutamide. Fertil Steril (1992) 1.42

An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab (2001) 1.42

Dengue virus type 3 in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz (2001) 1.37

Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest (1992) 1.36

Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab (1999) 1.35

Estrogen production and its origin in men with gonadotropin-producing neoplasms. J Clin Endocrinol Metab (1974) 1.30

A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med (2000) 1.29

Dose response for benzo(a)pyrene adducts in mouse epidermal DNA. Cancer Res (1979) 1.22

Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med (1996) 1.21

Mutation analysis of the 2 kb 5' to SRY in XY females and XY intersex subjects. J Med Genet (1996) 1.21

Effect of trichloroethylene on DNA methylation and expression of early-intermediate protooncogenes in the liver of B6C3F1 mice. J Biochem Mol Toxicol (1999) 1.19

Nuclear translocation of beta-catenin in hereditary and carcinogen-induced intestinal adenomas. Carcinogenesis (1998) 1.16

Haloacetonitrile excretion as thiocyanate and inhibition of dimethylnitrosamine demethylase: a proposed metabolic scheme. J Toxicol Environ Health (1984) 1.16

Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab (1998) 1.15

Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res (2003) 1.14

Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos Int (2006) 1.13

Effect of adrenergic blocking agents on the vasopressin inhibiting action of norepinephrine. Proc Soc Exp Biol Med (1970) 1.12

Interrelated effects of antidiuretic hormone and adrenergic drugs on water metabolism. Am J Physiol (1971) 1.11

Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab (1995) 1.11

Androgen production and metabolism in normal and virilized women. Metabolism (1972) 1.11

A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells. Mol Biol Cell (2000) 1.10

Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci U S A (2001) 1.10

Short-term in vivo initiation/promotion bioassay for hepatocarcinogens. J Environ Pathol Toxicol (1980) 1.09

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab (2006) 1.08

Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry (1994) 1.08

Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis (1999) 1.07

Fiber from whole grains, but not refined grains, is inversely associated with all-cause mortality in older women: the Iowa women's health study. J Am Coll Nutr (2000) 1.07

AREDYLD: a syndrome combining an acrorenal field defect, ectodermal dysplasia, lipoatrophic diabetes, and other manifestations. Am J Med Genet (1983) 1.07

Reversed-phase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations. J Chromatogr B Biomed Sci Appl (2001) 1.06

Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab (1996) 1.06

The potential role of physical activity in the prevention of non-insulin-dependent diabetes mellitus: the epidemiological evidence. Exerc Sport Sci Rev (1994) 1.05

Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis. J Clin Endocrinol Metab (1976) 1.04

Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J Clin Endocrinol Metab (2001) 1.04

Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care (2001) 1.03

Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl (1994) 1.03

Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Arch Dis Child (1999) 1.02

Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect Immun (2000) 1.01

Ectopic ACTH syndrome. J Steroid Biochem Mol Biol (1995) 1.00

Studies on oestriol synthesis from dehydroepiandrosterone sulphate in human pregnancy. Acta Endocrinol (Copenh) (1966) 1.00

Management of ambiguous genitalia in pseudohermaphrodites: new perspectives on vaginal dilation. Fertil Steril (1997) 1.00

Origin of an ovarian steroid cell tumor causing isosexual pseudoprecocious puberty demonstrated by the expression of adrenal steroidogenic enzymes and adrenocorticotropin receptor. J Clin Endocrinol Metab (2000) 0.99

The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab (1998) 0.98

[Mediastinal lipoma. Report of a case]. Arq Bras Cardiol (1983) 0.98

Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab (1998) 0.98

Simple, rapid and sensitive reversed-phase high-performance liquid chromatographic method for the determination of mefenamic acid in plasma. J Chromatogr (1989) 0.97

Biologic markers in hospital workers exposed to low levels of ethylene oxide. Mutat Res (1992) 0.97

Magnetic resonance guided focused ultrasound surgery. Ablation of soft tissue at bone-muscle interface in a porcine model. Eur J Clin Invest (2008) 0.97

Idiopathic hirsutism--an ovarian abnormality. N Engl J Med (1976) 0.97

Genotoxic properties of haloacetonitriles: drinking water by-products of chlorine disinfection. Fundam Appl Toxicol (1986) 0.96

A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol (1998) 0.96

The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol (1973) 0.96

A comparison of the lung adenoma response in strain A/J mice after intraperitoneal and oral administration of carcinogens. Toxicol Appl Pharmacol (1984) 0.96

Associations among physical activity, television watching, and obesity in adult Pima Indians. Med Sci Sports Exerc (1997) 0.96

21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol (2000) 0.96

Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis (1999) 0.95

Obesity, hormones, and cancer. Cancer Res (1981) 0.95

Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol Suppl (Copenh) (1971) 0.95

Trihalomethanes as initiators and promoters of carcinogenesis. Environ Health Perspect (1982) 0.95

Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence. Infect Immun (2000) 0.94

The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J Exp Med (1999) 0.94

Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen overproduction in hirsute women. J Clin Endocrinol Metab (1971) 0.94

Leydig cell function in men with gonadotrophin-producing testicular tumors. J Clin Endocrinol Metab (1970) 0.94

Therapeutic effects of spironolactone in polycystic ovary syndrome. Obstet Gynecol (1983) 0.93

Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. J Clin Endocrinol Metab (2001) 0.93

Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: prevention by methionine. Toxicol Sci (2000) 0.93

A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab (1998) 0.93

Inhibin alpha-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers. J Med Genet (2004) 0.93

Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett (2000) 0.92

Malignant lipid cell tumor of the ovary: clinical, biochemical and etiologic considerations. J Clin Endocrinol Metab (1970) 0.92

Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis (1999) 0.92

Detection of human parvovirus B19 in a patient with hepatitis. Braz J Med Biol Res (2001) 0.92

Results of toxicological testing of Jefferson Parish pilot plant samples. Environ Health Perspect (1986) 0.91

Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrinol Metab (1984) 0.91

Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study. Oral Oncol (2002) 0.91

Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG (2013) 0.91

Leptospiral antigens (L. interrogans serogroup ictero-haemorrhagiae) in the kidney of experimentally infected guinea pigs and their relation to the pathogenesis of the renal injury. Exp Pathol (1991) 0.91

Obesity, androgens, estrogens, and cancer risk. Cancer Res (1982) 0.91

Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem Biol Interact (1981) 0.91

Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children. Int J Obes (Lond) (2011) 0.91

Cancer chemoprevention agent development strategies for genistein. J Nutr (1995) 0.91

The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin Endocrinol (Oxf) (2000) 0.90

Pheochromocytoma: study of 50 cases. J Urol (1997) 0.90

MHC class I and II expression in juvenile dermatomyositis skeletal muscle. Clin Exp Rheumatol (2009) 0.90

[Nephropathic cystinosis: report of 2 cases and review of the literature]. Rev Assoc Med Bras (1994) 0.89